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Nance–Horan syndrome (NHS) is an X-linked developmental disorder, characterized by bilateral congenital
cataracts, dental anomalies, facial dysmorphism and mental retardation. Null mutations in a novel gene,
NHS, cause the syndrome. The NHS gene appears to have multiple isoforms as a result of alternative tran-
scription, but a cellular function for the NHS protein has yet to be deﬁned. We describe NHS as a founder
member of a new protein family (NHS, NHSL1 and NHSL2). Here, we demonstrate that NHS is a novel regulator
of actin remodelling and cell morphology. NHS localizes to sites of cell–cell contact, the leading edge of
lamellipodia and focal adhesions. The N-terminus of isoforms NHS-A and NHS-1A, implicated in the patho-
genesis of NHS, have a functional WAVE homology domain that interacts with the Abi protein family, haema-
topoietic stem/progenitor cell protein 300 (HSPC300), Nap1 and Sra1. NHS knockdown resulted in the
disruption of the actin cytoskeleton. We show that NHS controls cell morphology by maintaining the integrity
of the circumferential actin ring and controlling lamellipod formation. NHS knockdown led to a striking
increase in cell spreading. Conversely, ectopic overexpression of NHS inhibited lamellipod formation.
Remodelling of the actin cytoskeleton and localized actin polymerization into branched actin ﬁlaments at
the plasma membrane are essential for mediating changes in cell shape, migration and cell contact. Our
data identify NHS as a new regulator of actin remodelling. We suggest that NHS orchestrates actin regulatory
protein function in response to signalling events during development.
INTRODUCTION
Nance–Horan syndrome (NHS) (MIM 302350) is an X-linked
developmental disorder. Male patients exhibit severe congeni-
tal cataract, distinctive dental anomalies including supernu-
merary incisors and crown-shaped permanent teeth,
characteristic dysmorphic features (anteverted pinnae, long
face and prominent nasal bridge) and developmental delay
in approximately 30–50% of cases. Heterozygous females
show milder signs, typically posterior Y-sutural lens opacities
(1–4). Mutations in a novel gene, NHS, have been identiﬁed as
the cause of the syndrome (5,6). Interestingly, all mutations
identiﬁed to date as a cause of this syndrome are null
mutations (4–10).
The NHS gene is alternatively spliced and composed of 10
coding exons with at least ﬁve isoforms (Supplementary
Material, Fig. S1A). Isoforms NHS-A and NHS-1A are both
transcribed from exon 1 coding for a 1630 and 1651 amino
acid protein, respectively. These two isoforms differ in the
presence or absence of exon 3a (Supplementary Material,
Fig. S1A). Null mutations in exon 1 of the NHS gene are pre-
dicted to only affect isoforms NHS-A and NHS-1A, implying
that these isoforms are critical to the pathogenesis of NHS
(5,6). A large insertion mutation was also identiﬁed in the
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expression of Nhs1, the human NHS-A equivalent, and
results in bilateral total cataract (Xcat)( 11). We recently ident-
iﬁed copy number variation mutations of the NHS gene as a
cause of X-linked congenital cataract in patients lacking
other features of NHS (4). These non-recurrent rearrangements
of the NHS gene are also predicted to result in altered tran-
scriptional regulation.
Analysis of the mouse Nhs gene revealed expression from
embryonic day 9.5 in the ventral neural tube and supports a
role for NHS in the development of the lens, brain, heart
and limbic system (5,11,12). NHS isoforms have been
shown to be differentially expressed; isoforms containing
exon 1 are expressed in epithelia and localize to the cell per-
iphery, whereas isoforms lacking exon 1 were detected in
non-epithelial tissue and localize to the cytoplasm (12,13).
Interestingly, NHS-1A was recently shown to immunoprecipi-
tate with the tight junction protein ZO-1, suggesting that NHS
may have a role at tight junctions (13).
The cellular function for isoforms of the NHS protein is yet
to be deﬁned. To explore the function of the NHS protein, par-
ticularly isoforms NHS-A and NHS-1A which are critical to
the pathogenesis of NHS, we investigated NHS localization
and the cellular effect of NHS knockdown and identiﬁed inter-
acting protein partners. We demonstrate that NHS is essential
for maintaining cell morphology through the regulation of
actin cytoskeletal dynamics and suggest that an important
mechanism of remodelling of the actin cytoskeleton during
development would therefore be lost in patients with NHS.
RESULTS
Localization of NHS to sites of cell–cell contact
To explore the function of the NHS protein, in particular iso-
forms NHS-A and NHS-1A, we generated exon 1 isoform
speciﬁc and pan NHS antibodies (Supplementary Material,
Fig. S1A). Human epithelial colorectal adenocarcinoma
(Caco-2) cells express isoform NHS-1A, determined by RT–
PCR (data not shown). Both antibodies detected NHS at sites
ofcell–cellcontact,inCaco-2cells(Fig.1A).NHSlocalization
was most prominent at multicellular (tricellular) contacts
(Fig. 1A) (14) and the expression level reduced as the cells dif-
ferentiated (Supplementary Material, Fig. S2A). Further inves-
tigationinsubconﬂuentculturesalsorevealedNHSlocalization
at initial points of cell–cell contact (data not shown).
NHS localizes to the leading edge of lamellipodia
As the intensity of NHS staining at cell–cell contacts did not
correlatewithjunctionalmaturation,weexaminedthesubcellu-
lar localization of endogenous NHS in motile cells to test
whether there was a role for NHS in cell motility. We deter-
mined that rat mammary adenocarcinoma cells (MTLn3) cells
express isoform NHS-1A by RT–PCR (data not shown).
These cells can be stimulated with epidermal growth factor
(EGF) to generate lamellipodia, with well-studied actin
dynamics (15–18). Upon EGF stimulation, MTLn3 cells
exhibit early (1 min) and late (3 min) barbed end transients
(17,18). Endogenous NHS localized at the leading edge of
lamellipodia at both the early PLC/coﬁlin-dependent transient
Figure 1. NHS localizes to sites of cell contact, the leading edge of lamelli-
podia and focal adhesions. (A) Endogenous NHS (red) localized to sites of
cell–cell contact in Caco-2 cells, detected by an N-terminal isoform-speciﬁc
antibody (left panel) and a C-terminal pan NHS antibody (right panel).
Lower panel for each antibody staining is a higher magniﬁcation. Nuclei
were counterstained with DAPI. Staining for NHS (red) was prominent at tri-
cellular contacts (arrowheads). Scale bar 10 mm. (B) Endogenous NHS
(detected with pan NHS antibody; red) localized at the leading edge of lamel-
lipodia in stimulated MTLn3 cells at the late 3 min transient (arrowheads).
Cells were counterstained for F-actin (green). Top panel, unstimulated;
middle panel, 3 min stimulation; bottom panel, enlargement of boxed area
showing NHS at the leading edge of the lamellipod. Scale bar 10 mm.
(C) Live TIRF imaging of GFP-NHS-1A (green) in MCF7 cells revealed
NHS localization at cell junctions (arrowhead), the leading edge and
co-localization with actin puncta (arrows) and actin ﬁbres (red, top panel).
GFP-NHS-1A co-localized with the focal adhesion complex protein Lasp1
(red, bottom two panels). Scale bar 10 mm.
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WASP family/Arp2/3 complex-dependent transient (Fig. 1B).
NHS localization at the early transient implies that it may be
involved in the generation of barbed ends or is associated with
newly formed actin ﬁlaments. Binding to the actin network
early may also result in NHS localization at the leading edge
at later time points, as seen at the 3 min transient (Fig. 1B).
NHS co-localizes with focal adhesion complexes
We noted that NHS appeared to co-localize with F-actin puncta
behind the lamellipodium (Fig. 1B, Supplementary Material
Fig. S2B), suggestive of possible co-localization with nascent
adhesions (19). Therefore, we explored further the NHS associ-
ation with these actin-rich structures. A GFP-NHS-1A
(GFP-NHS) construct was used for live imaging in MCF7
cells. Total internal reﬂection ﬂuorescence microscopy (TIRF),
which penetrates toa depth of  100 nm enabling selective visu-
alization of the membrane and cytoplasmic zone close to the
membrane, revealed GFP-NHS-1Alocalization at cell–cell con-
tacts and at the leading edge (Fig. 1C), further conﬁrming the
localization observed for endogenous NHS in Caco-2 and
MTLn3 cells (Fig. 1A and B). In addition, GFP-NHS-1A
co-localized with actin ﬁbres (Lifeact-TagRed) and at speciﬁc
actin puncta (Fig. 1C). Lasp1 is a dynamic actin-binding
nascent focal adhesion protein required for cell migration (20).
To establish whether these structures were focal adhesions, we
examined NHS and Lasp1 (Lasp1-mCherry) localization in live
cells.NHSandLasp1werefoundtoco-localizeatfocaladhesion
complexes (Fig. 1C).
Collectively, the localization of NHS at cell–cell contacts,
the leading edge of lamellipodia and focal adhesions suggested
that NHS has an important role in dynamic actin structures.
We therefore addressed the question, what is the functional
link between NHS and the actin cytoskeleton?
NHS is a founder member of a new protein family
with homology to the WAVE proteins
To understand whether NHS has a direct role in actin cyto-
skeletal dynamics, we searched for potential homologies with
other proteins and speciﬁcally with actin-binding and
actin-associated proteins. We previously identiﬁed an NHS
paralogue, NHS-like 1 (NHSL1, Supplementary Material,
Fig. S3A) (6), which prompted a wider search for NHS paralo-
gues resulting in the identiﬁcation of NHSL2 (Supplementary
Material, Fig. S3A). NHS, NHSL1 and NHSL2 have conserved
genomic structure and appear to be present only in vertebrate
genomes (Supplementary Material, Fig. S3A). The analysis of
NHSL2 transcripts in human fetal cDNA detected expression
in all tissues tested and suggests that NHSL2 is also expressed
during development (Supplementary Material, Fig. S3B).
NHSL2 is more widely or abundantly expressed than NHS,
since in a similar analysis using the same human fetal cDNA
panel NHS expression was only detected in the fetal brain,
thymus, lung and kidney (6). We identiﬁed nine regions of
homology indicating common domains for this new protein
family (Supplementary Material, Fig. S3C).
Three human WAVE (WASP family Verprolin-homologous)
proteins have been identiﬁed, which are members of the
Wiskott–Aldrich syndrome protein (WASP) family (21).
Importantly, a sequence similarity was identiﬁed between the
N-terminus of NHS and the WAVE homology domain
(WHD) of the three human WAVE proteins (Fig. 2A). This
domain of the NHS protein (homology domain 1) is conserved
across the NHS protein family (Supplementary Material,
Fig. S3C and D), supporting the hypothesis that homology to
the WHD of the WAVE proteins may be functionally signiﬁ-
cant. Interestingly, this region of the NHS protein is only
present in isoforms encoded by exon 1 (NHS-A and
NHS-1A) which is conserved across species and critical to
the pathogenesis of NHS (Supplementary Material, Fig. S1B).
In mammals, the WASP protein family consists of four sub-
classes: WASP/N-WASP, WAVEs, WASH and WHAMM/
JMY (Supplementary Material, Fig. S1C) (21–25). The
WASP protein family are regulators of actin assembly, connect-
ing signalling molecules (Rho GTPases) to the activation of
the Arp2/3 complex (21–30). NHS also encodes proline-rich
and basic regions, which are common domains in WASP
proteins (Supplementary Material, Fig. S1C and D). WAVE
proteins are functional components of a large protein
complex (WAVE heteropentameric complex) that regulates
actin dynamics at the leading edge of motile cells initiating
lamellipodia formation downstream of the small GTPase Rac.
The WHD of the WAVE proteins is required for a direct inter-
action with the Abl interactor (Abi) family of proteins and
HSPC300 (30–34). Abi proteins are important regulators of
the WASP protein family, facilitating the formation of a hetero-
pentameric complex containing the WAVE proteins (WAVE/
Abi/HSPC300/Nap1/Sra1) and inﬂuencing WASP and
N-WASP-mediated processes (21–34). It is thought that the
heteropentameric complex either trans-inhibits the ability of
the WAVEs to activate the Arp2/3 complex (30) or is important
for correct localization of the WAVEs for actin polymerization
(32). Similar to WAVEs, Abi proteins localize to sites of actin
polymerization in protrusive membrane structures (35).
NHS encodes a functional WHD which interacts with all
three members of the Abi protein family, HSPC300, Nap1
and Sra1
To address whether the NHS-WHD was functional, we ﬁrst
used a targeted approach to test the ability of NHS to bind
Abi proteins. Full-length NHS (NHS-1A) co-immunoprecipi-
tated with all three members of the Abi family (Fig. 2B).
We then tested whether the NHS-WHD alone (amino acids
1–262) was necessary and sufﬁcient to bind the Abi family.
Co-immunopreciptation assays demonstrated the binding of
the ﬁrst 262 amino acids of the NHS protein with all Abi
family members (Fig. 2B). The two Abi species detected on
these blots represent phosphorylated (higher MW) and unpho-
sphorylated (lower MW) forms of the Abi proteins (36).
Endogenous Abi1 was also shown to co-immunoprecipitate
with NHS-WHD (Fig. 2C).
To identify additional novel interactors of NHS, we also
performed a yeast two-hybrid (Y2H) screening using an E17
mouse embryo library as the prey and the WHD of NHS as
the bait (amino acids 1–262). An E17 embryo library was
selected as the prey, since NHS has been shown to be
expressed as early as E9.5 and clearly has a role in normal
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resulted in the identiﬁcation of two cDNAs encoding
HSPC300 from the Y2H library screening. HSPC300 is a
member of the WAVE heteropentameric complex and directly
interacts with the WHD of all three WAVE proteins (31). Both
NHS-WHD and NHS-1A interacted with HSPC300 in yeast
(Fig. 2D). This demonstrates that the interaction of NHS
with HSPC300 is a direct interaction (i.e. not mediated by
WAVE or Abi) since the WAVE complex is not present
in yeast. The interaction of HSPC300 with NHS was further
conﬁrmed by co-immunoprecipitation (Fig. 2E).
In addition to direct binding of HSPC300 and Abi proteins
to the WHD of WAVEs, the Abi proteins also bind Nap1 (Nck
associated protein-1), facilitating recruitment of Nap1 to the
heteropentameric WAVE complex. Sra1 (speciﬁcally Rac1-
associated protein 1) is recruited to the complex through
binding to Nap1 (30–32). Binding of the RhoGTPase Rac1 to
Sra1 links Rho GTPase signalling to the Arp2/3 complex via
the WAVE heteropentameric complex (32). Since HSPC300
interacts directly with the NHS-WHD, independent of Abi
binding, and all Abi proteins also bind to the NHS-WHD, we
tested the ability of NHS to co-immunoprecipitate the two
Figure 2. NHS contains a functional WHD which interacts with the Abi family of proteins, HSPC300, Nap1 and Sra1. (A) Schematic representation of the NHS
protein and identiﬁed domains with an alignment of the N-termini of human NHS, WAVE1, WAVE2 and WAVE3. Letters in bold beneath the alignment denote
conserved residues in mammalian WAVEs, Drosophila SCAR and Dictyostelium SCAR. The Abi binding domain is underlined. (B) Western blot analysis of
immunoprecipitated FLAG-tagged Abi proteins to detect binding to Myc-tagged full-length NHS (NHS-1A) and NHS-WHD. IP, immunoprecipitation; WB,
western blot. (C) Western blots of co-immunoprecipitated endogenous Abi1 with Myc-tagged NHS-WHD. IP, immunoprecipitation; WB, western blot. The
expression of NHS-WHD resulted in increased levels of non-phosphorylated Abi1 (denoted by an arrowhead in the input panel). NHS-WHD preferentially
co-immunoprecipitated non-phosphorylated Abi1. (D) Y2H library screening identiﬁed HSPC300 as a putative interactor. Both NHS-1A and NHS-WHD facili-
tated yeast growth on selective media with transcription of the reporter gene. The HSPC300-binding domain in NHS was therefore deﬁned as the WHD (amino
acids 1–262). Control (empty vector) did not grow on selective media. (E) Western blots of immunoprecipitated FLAG-tagged HSPC300 with Myc-tagged
NHS-1A and NHS-WHD. IP, immunoprecipitation; WB, western blot. Asterisk in western blots denotes the antibody heavy chain. (F) Western blots of immu-
noprecipitated endogenous Nap1and Sra1 with Myc-tagged NHS-1A and Myc-tagged NHS-WHD. IP, immunoprecipitation; WB, western blot.
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Nap1 and Sra1. Endogenous Nap1 and Sra1 both
co-immunoprecipitated withNHS-1A andNHS-WHD(Fig.2F).
Importantly, these data demonstrate that the WHD in NHS
is functionally similar to the WHD described in WAVE
proteins. The identiﬁcation of these novel protein partners of
NHS, which are known to form a pentameric complex with
the WAVE proteins, combined with our data localizing NHS
to dynamic actin-rich structures, suggests that NHS has a
direct role in actin dynamics. Therefore, we tested the
hypothesis that NHS is required for dynamic actin cytoskeletal
remodelling.
Depletion of NHS disrupts the circumferential actin
ring and cell morphology
In epithelia, lamellipodial structures facilitate cell–cell
adhesion, giving rise to cell–cell contacts. Clustering of cad-
herin junctions at points of contact between cells leads to
the formation of actin bundles, which associate with cadherin
clusters. New actin ﬁlaments are then recruited to the sites of
cell–cell contact as they lengthen, eventually forming a cir-
cumferential actin ring (37). Polarization then occurs leading
to junction maturation and a cuboidal morphology. To test
whether NHS has a role in actin cytoskeletal assembly,
Caco-2 cells were treated with short interfering RNA
(siRNA) targeting all known NHS isoforms.
Cells treated with NHS siRNA (targeted to the 3′-UTR)
appeared larger and did not exhibit a typical cuboidal mor-
phology (Fig. 3A). Quantiﬁcation revealed a 2.5-fold increase
in the cell surface area of cells treated with NHS siRNA
(Fig. 3B). The localization of most junctional proteins (includ-
ing ZO-1) was unaffected following NHS knockdown. In con-
trast, a-catenin appeared more diffuse at points of cell–cell
contact (Fig. 3A). Staining for F-actin in NHS-depleted cells
revealed the disruption of the circumferential actin ring
(Fig. 3C). In comparison to cells treated with control
siRNA, NHS-depleted cells exhibited a diffuse, non-linear
F-actin structure at the periphery (Fig. 3C). These data
show that NHS is essential for maintaining the integrity of
the circumferential actin ring and cell morphology.
NHS knockdown causes rearrangement of the actin
cytoskeleton and excessive cell spreading and lamellipod
extension
The WAVE heteropentameric complex proteins co-localize at
the leading edge of lamellipodia. Localization of the WAVE
proteins to the leading edge is dependent on their WHD and
subsequent incorporation into the heteropentameric complex
(38,39). To determine whether the WHD of NHS facilitates
localization to the leading edge of lamellipodia, we expressed
NHS-1A and NHS-WHD in MTLn3 cells. Both NHS-1A and
NHS-WHD localized to the leading edge of lamellipodia in
stimulated cells (Fig. 4A). NHS was not detected at the
periphery of unstimulated MTLn3 cells (Supplementary
Material, Fig. S2C). Co-expression of NHS-WHD, with either
FLAG-Abi3 or FLAG-HSPC300, revealed co-localization
throughout the cell and at the leading edge of lamellipodia in
stimulated cells (Supplementary Material, Fig. S2D). These
Figure 3. NHS is essential for organization of the circumferential actin ring. (A) Knockdown of NHS in Caco-2 cells resulted in larger cells, loss of a cuboidal
cell shape and a diffuse localization of a-catenin (green) at the cell periphery. Scale bar 10 mm. Nuclei stained with DAPI (blue). (B) NHS siRNA treatment
resulted in a 2.5-fold increase in cell area. For each condition, 100 cells from two independent experiments were measured. Error bars are +standard deviation.
(C) The thick circumferential ring of actin bundles (counterstained for F-actin, green) aligned with the cell borders was disrupted in NHS-depleted cells. Nuclei
stained with DAPI (blue). Scale bar 10 mm.
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podia is mediated, at least in part, by the NHS-WHD.
To explore the role of NHS at the leading edge, we then
treated MTLn3 cells with NHS siRNA, which resulted in a
striking excessive cell spreading phenotype (Fig. 4B) consistent
with our previous observations with Caco-2 cells (Fig. 3). Cells
with reduced NHS expression also displayed rearrangement of
the actin cytoskeleton. Filamentous actin appeared to coalesce
forming focal points from which actin ﬁlaments radiated, remi-
niscent of a spoke wheel (Fig. 4B). We then addressed whether
NHS knockdown functionally altered lamellipod extension by
quantiﬁcation of the cell surface area in NHS siRNA-treated
resting and EGF-stimulated MTLn3 cells, as cell area increase
in response to EGF is a reliable marker of lamellipod extension
in these cells (15–18,40). NHS knockdown led to a 3-fold
increase in cell area compared with the unstimulated control
siRNA-treated cells and a 2-fold increase compared with the
stimulated siRNA-treated cells. The NHS siRNA-treated cells
no longer increased in size on EGF stimulation, suggesting
that this pathway has been dysregulated (Fig. 4C). The exces-
sive cell spreading and lamellipod extension phenotype of
NHS siRNA-treated cells was rescued by the ectopic expression
of an siRNA-resistant NHS-1A construct (Fig. 4D and E).
Collectively, our data demonstrate that NHS regulates actin
assembly and cell spreading. Our data also suggest that there
is interplay between the WAVE heteropentameric complex
and NHS at speciﬁc sites of dynamic remodelling. NHS may
regulate turnover, displace or compete for the complex and
negatively regulate WAVE function, which would be consistent
with the observation that the absence of NHS leads to excessive
Figure 4. NHS knockdown results in excessive cell spreading and lamellipod formation. (A) Ectopic expression of full-length (Myc-NHS-1A) and WHD
(Myc-NHS-WHD) NHS constructs in MTLn3 cells after 3 min EGF stimulation. NHS constructs are in red and F-actin in green. NHS-1A and NHS-WHD localized
at the leading edge after EGF stimulation (arrowheads). Scale bar 10 mm. (B) Knockdown of NHS expression results in increased cell spreading and lamellipod
formation in stimulated and unstimulated MTLn3 cells. Cells were stained with the pan NHS antibody (red) and counterstained for F-actin (green). NHS siRNA-
treated stimulated cells also displayed the re-arrangement of actin stress ﬁbres (arrows) radiating from ‘spoke wheels’. Scale bar 10 mm. Lower panel for each is a
higher magniﬁcation. (C) NHS knockdown cells did not spread in response to EGF stimulation. Cell area measurements for MTLn3 cells treated with control or
NHS siRNAs in the presence (stimulated) and absence (unstimulated) of EGF. A total of 200 cells from two independent experiments were measured for each
condition. Addition of EGF for 3 min increased cell area in control siRNA treated cells. No signiﬁcant difference in cell area was observed in the presence/
absence of EGF for NHS siRNA treated cells. Error bars are +standard deviation. (D) Following siRNA treatment, the ectopic expression of siRNA-resistant
NHS-1A (green) rescued the excessive cell spreading phenotype in unstimulated MTLn3 cells. Top panel: empty GFP vector control; bottom panel: NHS-1A
rescue. Cells were counterstained for F-actin (red) Scale bar 10 mm. (E) Cell area measurements for unstimulated MTLn3 cells transected with either control
(GFP) or NHS-1A following NHS siRNA treatment. The mean area of 26 GFP expressing cells and 21 NHS-1A expressing cells are shown +standard deviation.
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may also have a role in co-ordinating a balance between actin-
based protrusion and adhesion in lamellipodia.
NHS and WAVE complex interplay
The activated WAVE complex at the leading edge of lamelli-
podia promotes actin polymerization at the plasma membrane
by activating the Arp2/3 complex (40,41). We therefore tested
whether an altered localization of complex members in the
absence of NHS could be responsible for this dysregulation.
WAVE and NHS protein partners Abi1 and HSPC300, and
the p34 subunit of the Arp2/3 complex, consistently localized
at the edges of cells treated with NHS siRNA, independent of
EGF stimulation and WAVE complex activation (Fig. 5A;
Supplementary Material, Fig. S4A). These data suggest that
in the absence of NHS, the translocation of Abi1 is dysregu-
lated. Furthermore, ectopic expression of NHS-1A inhibited
the ability of cells to respond to EGF stimulation, as mean
lamella area was signiﬁcantly reduced compared with controls
(Fig. 5B). These data indicate that cells overexpressing NHS
lose the capacity to fully activate the WAVE complex.
Figure 5. NHS is essential for co-ordinated actin regulatory protein dynamics. (A) Knockdown of NHS results in lamellipod formation and consistent localiz-
ation of Abi1, HSPC300 and Arp2/3 at the cell membrane in the absence of EGF. Endogenous Abi1, HSPC300 and Arp2/3 were localized in unstimulated and
EGF-stimulated (3 min) MTLn3 cells after treatment with control or NHS siRNAs. Abi1, HSPC300, and the p34 subunit of Arp2/3 are in red, F-actin in green.
Scale bar 10 mm. (B) Ectopic expression of NHS-1A inhibited the ability of cells to respond to EGF stimulation. Cell lamella area measurements for stimulated
or unstimulated MTLn3 cells transfected with either control (NHS-C) or NHS-1A +standard deviation. Cells transfected with NHS-1A containing the WHD fail
to extend lamellipods compared with the NHS-C construct lacking the WHD (∗P , 0.001). (C) NHS depletion in Caco-2 cells caused mislocalization of Arp2/3
(red) and Abi1 (red). Scale bar 10 mm.
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actin ring in Caco-2 NHS knockdown cells (Fig. 3C), we
examined endogenous Abi1 and Arp2/3 localization in these
cells. Localization of Abi1 at sites of cell–cell contact was
disrupted in NHS siRNA cells compared with controls
(Fig. 5C). Furthermore, Arp2/3 localization at cell borders
was disrupted in the absence of NHS, resulting in a diffuse
localization at the cell periphery (Fig. 5C), consistent with
the disrupted F-actin distribution (Fig. 3C).
These data show that localization of Abi1 and HSPC300
was altered in the absence of NHS. Importantly, in the
absence of NHS, Arp2/3 localization and F-actin distribution
are disrupted, suggesting that Arp2/3 actin-nucleation activity
is mediated, in part, by NHS providing an additional func-
tional link between NHS and actin. Interestingly, our data
also suggest that the cellular response to EGF is bypassed in
the absence of NHS or suppressed in the presence of NHS,
implying that NHS may modulate responses to extracellular
signalling.
DISCUSSION
NHS associates with actin-rich structures and controls
cell morphology
Our data show that the NHS protein, which is essential for
normal embryonic development, has a key role in maintaining
cell morphology. NHS stabilizes the circumferential contrac-
tile actin ring which is essential for providing strength for
cell adhesion and generating cell shape. The observation that
a-catenin and F-actin localization was disrupted in NHS
knockdown Caco-2 cells, but other junctional protein localiz-
ation was unaffected, implies that NHS is required for the for-
mation of a stable link between the cadherin/b-catenin
complex and the actin cytoskeleton, but not essential for junc-
tion formation. This hypothesis is supported by the enlarged
and non-cuboidal morphology observed in NHS knockdown
cells. Recent evidence suggests that different conformational
states of a-catenin confer its ability to form a stable link
between the cadherin/b-catenin complex and the actin cytos-
keleton (42). The disruption of circumferential F-actin and
a-catenin as a result of NHS knockdown, but not E-cadherin
localization, supports the hypothesis that there is a dynamic
interaction between a-catenin and the actin cytoskeleton. In
Caco-2 cells, we also observed the downregulation of NHS
expression upon differentiation. This is consistent with the
observation that NHS transcript expression in the anterior
lens vesicle and ﬁbre cells becomes progressively restricted
to the anterior lens epithelium during lens development (12)
and supports a role for NHS early in cell differentiation as
opposed to junctional maturation.
In addition to their role in facilitating cell–cell adhesion,
through cell–cell contacts, lamellipodial structures are essen-
tial for cell motility. We show that NHS also controls lamelli-
pod protrusions in motile cells. NHS localized at the leading
edge of lamellipodia of stimulated MTLn3 cells. The
rearranged actin cytoskeleton and excessive cell spreading
phenotype observed following NHS knockdown in these
cells, resulting from excessive lamellipod extension, is con-
sistent with our observations in Caco-2 cells. These data
demonstrate that NHS has a key role in maintaining the
robust cytoskeletal architecture required for cell stability and
in controlling cytoskeletal plasticity to allow remodelling.
Our data show that NHS maintains cell shape by stabilizing
cortical actin structures and suggest that lack of this control
leads to overactive dynamic lamellipod formation. The corti-
cal actin stabilization function of NHS is facilitated, at least
in part, through a functional WHD.
Nascent adhesions are myosin II-independent and serve as
precursors for focal adhesions. They assemble in the lamelli-
podium and their rate of assembly is linked to protrusion
rate and Arp2/3 actin polymerization (19). Even though the
lamellipodial actin structure has been well described, the
precise organization of the actin ﬁlaments that emerge from
focal adhesions is poorly understood. Interestingly, NHS
also localized to speciﬁc actin puncta behind the leading
edge of the lamellipodium and co-localized with focal
adhesion complexes implicating that NHS may have a role
at the site of nascent adhesion assembly.
NHS regulates actin cytoskeletal dynamics
We describe NHS as the ﬁrst human protein to contain a func-
tional WHD since the discovery of the WAVE proteins. Enor-
mous progress has been made to understand WAVE
heteropentameric complex assembly and WAVE complex
activation and function in the formation of the Rac-dependent
membrane structures. However, the mechanism by which Rac
regulates the WAVE complex is the subject of some debate
and the mechanisms controlling WAVE heteropentameric
complex assembly and disassembly have yet to be deﬁned.
We show that the WHD of NHS interacts with the Abi
family of proteins, HSPC300, Nap1 and Sra1, and is important
for the localization of NHS to the leading edge. We hypoth-
esize that NHS affects the WAVE function, either by control-
ling assembly of the WAVE complex or by regulating the rate
of WAVE complex assembly. In support of this hypothesis is
the similarity of the phenotype of NHS knockdown in Caco-2
and MTLn3 cells to increased cell spreading of pirA (the
Sra1 homologue) null Dictyostelium discoideum cells (43).
The pirA null cells continually extended new pseudopods
and the phenotype is thought to be due to overactive Scar
(WAVE) protein function, as pirA negatively regulates the
WAVE protein (43). Furthermore, Scar (WAVE) knockout
Dictyostelium cells show reduced adhesion to the substratum,
indicating a conserved association between the role of WAVE
complex in adhesion and in protrusion of lamellipods and
pseudopods (44). Therefore, excessive cell spreading and
lamellipod extension as a result of NHS knockdown is likely
to be a result of loss of WAVE complex regulation, leading
to overactive WAVE activity or a dysregulation of nascent
focal adhesions in lamellipodia.
NHS knockdown also resulted in the mislocalization of the
Arp2/3 complex and disruption of the actin cytoskeleton. This
implies that NHS function in controlling actin dynamics is
mediated by regulating the Arp2/3 complex, which may be
indirect as a result of negative regulation of the WAVEs, or
by a direct effect of NHS function. The precise mechanism
by which NHS controls actin dynamics is yet to be deter-
mined, and in this study, we have focused on the N-terminal
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protein confer additional functions affecting the interplay
between NHS, the WAVE complex and actin. Since actin
assembly factors work in concert, NHS may function as a
key scaffold protein which controls the balance between
cell adhesion and motility by coordinating the function of
multiple regulatory pathways important for actin stability
and plasticity.
The NHS protein family
Our study has focused on understanding the function of the
N-terminal domain, encoded by exon 1 of the NHS gene.
Importantly, NHS, NHSL1 and NHSL2 are much larger pro-
teins and differ markedly from the WAVEs, with multiple
shared protein domains of unknown function. The expression
of different NHS protein family members is likely to be
co-ordinated in a spatiotemporal manner during development.
We predict that the WHDs we identiﬁed in NHSL1 and
NHSL2 will also be functional and that they will have a role
in regulating actin dynamics. However, these proteins appear
to have no functional redundancy in the developing lens,
brain and craniofacial tissues as highlighted by the lack of
NHS in NHS patients. Investigation of the cellular and subcel-
lular localization of NHSL1 and NHSL2, and their association
with actin-rich structures, will be an important next step in
understanding the function of this protein family.
Loss of NHS isoforms containing a functional WHD
causes NHS
The NHS gene was ﬁrst identiﬁed as the gene mutated in
patients with a developmental disorder, NHS. Since null
mutations have been identiﬁed in exon 1, which encodes only
isoforms NHS-A and NHS-1A, these isoforms are known to
be critical to the pathogenesis of NHS (5,6). In this study, we
show that isoforms NHS-A and NHS-1A differ from other
NHS isoforms in that they contain a WHD. Interestingly,
NHS could co-immunoprecipitate all three Abi proteins.
Which Abi proteins are the physiological partners of NHS is
not clear. For example, NHS may preferentially bind one or
more Abi’s in vivo, and it is also likely that speciﬁcity is gov-
erned by spatiotemporal expression of both proteins. Abi2 is
highly expressed in the lens and plays a pivotal role in the
development of the anterior and posterior sutures (45). This
suggests that an NHS–Abi2 interaction may be physiologically
important for lens development and that null mutations in the
NHS gene could cause congenital cataract by disruption of
this interaction and the actin cytoskeleton. In support of the
potential importance of an NHS–Abi2 interaction in the patho-
genesis of NHS, Abi2 null mice also exhibit deﬁcits in learning
and memory, and similarly, NHS patients often have behaviour-
al problems and developmental delay (3,4,45).
In summary, our data demonstrate that NHS has an impor-
tant role in regulating cell morphology and functions as a
novel actin regulatory protein. We suggest that NHS orches-
trates the activity of other actin regulatory proteins to build
speciﬁc cytoskeletal structures in response to cellular signals
during development. These new ﬁndings and further research
on the function of NHS and other family members will
impact on our understanding of how tissues are shaped
during development.
MATERIALS AND METHODS
Cell culture and stimulation
BE and Caco-2 cells were cultured in a Dulbecco’s modiﬁed
Eagle’s medium (DMEM) medium (Gibco BRL), MTLn3
cells were cultured in an MEMa medium (Gibco BRL) and
CHO cells in a DMEM–F12 medium (Gibco BRL). All cell
culture mediums contained 10% fetal bovine serum (Gibco
BRL), supplemented with 100 IU/ml penicillin and 100 IU/
ml streptomycin (Invitrogen). Cells were grown at 378Ci n
the presence of 5% CO2. Cells were transfected with 100 ng
of each DNA plasmid using Lipofectamine plus (Invitrogen)
according to the manufacturer’s instructions. Glass cover
slips were pre-treated prior to seeding MTLn3 cells. Brieﬂy,
chamber slides were washed for 5 min in 1 M HCl, rinsed
with 1× PBS, washed in 95% ethanol for 2 min, and then
rinsed twice in 1× PBS. MTLn3 cells were cultured, starved
and stimulated with murine natural EGF (Invitrogen) as pre-
viously described (37). MCF7 cells were cultured in DMEM
medium supplemented with 10% fetal bovine serum and
2m ML -glutamine (Gibco BRL) and maintained at 378C with
5% CO2. MCF7 cells were transfected using Amaxa Nucleo-
fector Kit V (Lonza, VCA-1003). For live imaging of MCF7
cells, DMEM/F12 (1:1) medium (Gibco BRL) supplemented
with 10% fetal bovine serum and 2 mML -glutamine was
used to culture cells for microscopy.
Antibodies and reagents
An N-terminal, isoform speciﬁc anti-peptide antibody (NHS-1A
and NHS-A) was raised against amino acids 2–13 (PFAKRI-
VEPQWL) of the NHS protein and afﬁnity puriﬁed (Eurogen-
tec, Belgium). A second pan NHS anti-peptide antibody was
raised against the C terminus of NHS, amino acids 1639–
1652 (DGSPHDDRSSQSST) (Sigma Genosys). The following
antibodies were used: mouse monoclonal anti-c-Myc 9E10
and M2 clone anti-FLAG (Sigma), rabbit polyclonal anti-p34,
mouse monoclonal C4 anti-actin (Chemicon). Mouse mono-
clonal antibodies against occludin and ZO-1 were obtained
from Zymed. Anti-GAPDH mouse monoclonal antibody was
purchased from Sigma. Polyclonal rabbit Abi1 antibody was a
kind gift from Alexis Gautreau. The polyclonal rabbit
HSPC300 antibody was a generous gift from Theresia Stradal.
A goat polyclonal antibody against E-cadherin, rabbit polyclo-
nal against a-catenin and mouse monoclonal against AF-6 were
a kind gift from Karl Matter. Alexa Fluor 488 phalloidin was
obtained from Invitrogen. Rabbit polyclonal antibodies against
Nap1 and Sra1 were obtained from Upstate Biotech.
Expression constructs
Full-length human NHS (amino acids 1–1652; NHS1A), the N
terminus (amino acids 1–262; NHS-WHD) and the C terminus
(amino acids 492–1651) were ampliﬁed by RT-PCR from
human BE carcinoma cells and cloned into pCMV-Tag3b (Stra-
tagene) to create constructs Myc-NHS1A, Myc-NHS-WHD and
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acids 1–1652) was also cloned into pEGFP-C2 (Clontech) to
create GFP-NHS1A for live imaging. Abi1, Abi2 and Abi3
were ampliﬁed from human cDNA clones: AU77-e10,
AU7-b4 and AU34-b2 (MRC geneservice), respectively, and
cloned into either pCMV-Tag2b (Stratagene) or p3 ×
FLAG-CMVTM-14 (Sigma). The pCDNA5-FLAG-
HA-HSPC300 construct was a gift from Alexis Gautreau.
Empty pcDNA3-TagRed was a gift from Kurt Anderson and
Lasp1-mChery was a gift from Bradford Ozanne. Lifeact
was released from lifeact-GFP (a gift from Roland Wedlich-
Soldner) and cloned into pDNA3-TagRed.
Y2H screening
Novel NHS interacting partners were identiﬁed using the
Matchmaker GAL4 two-hybrid system 2 (Clontech). A
17-day mouse embryo cDNA library was obtained from
Clontech in the vector pGADT7-Rec, pre-transformed into
Saccharomyces cerevisiae yeast strain Y187. Full-length
human NHS-1A cDNA (nt 1–4956) and the WHD domain
of human NHS (nt 1–788; NHS-WHD) were cloned into the
yeast expression vector pGBKT7 in frame with the GAL4
DNA-binding domain. The NHS-WHD bait construct was
used to transform S. cerevisiae yeast strain AH109 using the
manufacturers protocols (Clontech). The mating procedure
was performed according to the manufacturer’s protocols
(Clontech). Approximately 2.4 × 10
7 clones from the 17-day
mouse embryo library were screened. Positive colonies were
picked and re-streaked on fresh SD/-Ade/-His/-Leu/-Trp agar
plates. Extracted yeast plasmids were electroporated into
Escherichia coli JM109 cells and plasmid DNA was puriﬁed
using manufacturer’s protocols (Sigma). Co-transformation
of the bait pGBKT7-NHS plasmids (full-length and partial
cDNAs) with each of the prey-positive plasmids was per-
formed in AH109 to conﬁrm positive interactions. Positive
prey plasmids, conﬁrmed by co-transformation, were
sequenced and cDNA sequences were initially analysed
using the BLAT algorithm at UCSC.
Immunoprecipitation assays
CHO cells were transfected with 100 ng of either,
Myc-NHS1A (amino acids 1–1652), Myc-NHS-WHD
(amino acids 1–262; WHD-NHS) or Myc-WAVE1 and
100 ng of Flag-tagged Abi1, Abi2, Abi3 or HSPC300. For
co-immunoprecipitation of endogenous Abi1, CHO cells
were transfected with 100 ng Myc-NHS-WHD. Twenty-four
hours later, cells lysed in Kinase lysis buffer (150 mM NaCl,
10 mM sodium phosphate pH 7.4, 1% Triton X-100, phospha-
tase inhibitors: Cantharidin, Bromotetramisole, Microcystin
LR, protease inhibitors: AEBSF, Aprotinin, Leupeptin, Besta-
tin, Pepstatin A, E-64) were cleared by centrifugation
(20 000g, 30 min) and incubated overnight with 4 mg of anti-
FLAG antibody. The following day, 50 ml of a 50% slurry of
G Sepharose beads (GE Healthcare) in Kinase lysis buffer was
added to the overnight lysates and incubated at 48C for 3 h.
Beads were washed four times in 40-fold bed volume of strin-
gent Kinase lysis buffer (500 mM NaCl) pH 7.4 and then resus-
pended in 50 ml2 × SDS sample buffer. A volume of 10 mlo f
bead sample and 5 ml supernatant were analysed by SDS–
PAGE and western blotting. For co-immunoprecipitation of
endogenous Nap1 and Sra1, A431 cells were transfected
with 100 ng of either Myc-NHS-1A or Myc-NHS-WHD.
Cells were lysed 24 h post-transfection by incubating with
TNE buffer (Tris 50 mM, NaCl 150 mM, 1% Triton X-100,
1m M EDTA, 1 mM protease inhibitors) on ice for 10 min.
Cell lysates were centrifuged at 20 000 g for 10 min. Super-
natant was aspirated and mixed with 50 ml anti-c-Myc
Agarose beads (Sigma) prewashed six times with 1× PBS
and incubated overnight at 48C. Beads were then washed
three times with TNE buffer. Washed beads were boiled
with NuPAGE reducing agent and 4× loading buffer.
Samples were centrifuged and the supernatant analysed by
SDS–PAGE and western blotting.
RNA interference
Pools of siRNAs directed against human NHS (sense strand:
5′-GCGCUAAACCCUCAGCAUA-3′,5 ′-CGACAAUGGUU
UAUGGACU-3′,5 ′-GUGGACAUGUGGUCAAUUA -3′,5 ′-GU
ACAGAGACUGAGCCUAU-3′) and control siRNAs (ON-
TARGETplus SMARTpools) were purchased from Dharma-
con (Lafayette, CO, USA). Dharmafect transfection reagents
1 and 4 were used to transfect MTLn3 and Caco-2 cells,
respectively. Caco-2 cells or MTLn3 cells were attached to
0.8 cm
2 eight-well glass chamber slides at a seeding density
of 10 000 cells. Cells were transfected the following day
with siRNA oligonucleotides (100 nM) for 72 h using Dhar-
mafect transfection reagent in complete, antibiotic-free
media. The cultured cells were then ﬁxed and processed for
immunoﬂuorescence analysis.
siRNA deconstruction and rescue
Individual siRNAs from the NHS siRNA pool were obtained
from Dharmacon and tested separately in MTLn3 cells.
siRNA sequence 5′-GUGGACAUGUGGUCAAUUA-3′ tar-
geting the 3′-UTR of the NHS gene resulted in effective
NHS knockdown and the same phenotype observed for the
NHS siRNA pool. To rescue the NHS knockdown phenotype
obtained with the NHS 3′-UTR siRNA, cells were treated with
50 nM siRNA for 48 h, then transfected with 100 ng of an
siRNA-resistant Myc-NHS1A construct and incubated for
24 h before ﬁxation and staining. The control experiment
was run in parallel in which MTLn3 cells treated with
50 nM NHS 3′-UTR siRNA were transfected with 100 ng of
pEGFP-N1 (Clontech).
Immunoﬂuorescence confocal microscopy
Caco-2 cells were ﬁxed in 100% methanol for 10 min. MTLn3
cells were ﬁxed for 15 min in 4% formaldehyde and permea-
bilized in 0.3% Triton X-100 for 15 min. Cells were then incu-
bated with primary antibody for 2 h, followed by incubation
with secondary antibody for 1 h. F-actin was detected by stain-
ing with Alexa Fluor 488 Phalloidin. DNA was counterstained
with DAPI (4,6-diamidino-2-phenylindole). All cell images
were captured using a Zeiss LSM 510 confocal microscope.
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After transfection, 5 × 10
4–1× 10
5 MCF7 cells were plated
on collagen G-coated 35 mm glass bottom dishes (IWAKI).
Cells were then incubated, as described, overnight. Just prior
to imaging, the medium was replaced with DMEM/F12 (1:1)
supplemented with 10% fetal bovine serum and 2 mM
L-glutamine for live cell imaging. TIRF was performed on a
Nikon Eclipse TE 2000-U microscope. The Nikon Epi-
ﬂuorescence condenser was replaced with a custom condenser
in which laser light was introduced into the illumination
pathway directly from the output of a 3.5 mm optical ﬁbre
oriented parallel to the optical axis of the microscope. GFP
and RFP excitation were performed at 473 and 561 nm,
respectively, using individually coupled diode lasers
(Omicron) controlled by a DAC 2000 card running Meta-
Morph (Molecular Devices). All cell images were captured
with a Cascade 512F EMCCD camera (Photometrics UK).
Bioinformatics
NHS orthologues were identiﬁed either through protein data-
base searches using the BLAST algorithms TBLASTP and
TBLASTX or through BLASTX against species-speciﬁc data-
bases at NCBI or through BLAT analysis using the UCSC
genome browser. To identify potential homologies with
other proteins/classes of protein, the human NHS protein
sequence was used as a query to perform a position-speciﬁc
iterated BLAST (PSI-BLAST) search.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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